GO:0071104 response to interleukin-9: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071104 (response to interleukin-9) describes any cellular or organismal change triggered by the cytokine interleukin-9 (IL-9), including movement, secretion, enzyme production and gene expression.
• IL-9 is produced mainly by CD4+ T helper cells, including Th9 and T follicular helper cells, and acts on multiple cell types such as B cells, mast cells, epithelial cells and macrophages.
• The response to IL-9 is central to type 2 immunity, tissue repair, fibrosis, allergy, asthma and anti-tumor immunity.
• IL-9 signaling promotes germinal center development of memory B cells through a ZBTB18-dependent axis, linking this GO term to humoral immunity.
• Dysregulated IL-9 responses contribute to alcoholic liver injury, cancer progression and variable responses to anti-TNF therapy in ankylosing spondylitis.
• CRISPR knockout, knock-in, point-mutation and overexpression models are key tools for dissecting the causal roles of genes acting within the response to interleukin-9.
Description
GO:0071104, response to interleukin-9, is a biological process Gene Ontology term defined as any process that results in a change in state or activity of a cell or an organism as a result of an interleukin-9 stimulus. Interleukin-9 (IL-9) is a pleiotropic cytokine produced predominantly by CD4+ T helper cells, including Th9 cells and T follicular helper cells, and it signals through the IL-9 receptor to modulate gene expression, secretion and cellular behavior in target cells. Because the term captures the full spectrum of downstream consequences of IL-9 exposure, it is a useful annotation for studies of type 2 immunity, mucosal barrier function and immune cell crosstalk. Researchers study GO:0071104 to understand how IL-9 shapes antibody responses, allergic inflammation, tissue remodeling and anti-tumor immunity. For example, IL-9 mediates T follicular helper cell activation to promote antibody responses, and an IL-9-ZBTB18 axis promotes germinal center development of memory B cells. In parallel, single-cell transcriptomic analysis of allergen-specific T cells has highlighted IL-9-associated programs in allergy and asthma, underscoring the clinical relevance of this response. Mechanistically, the response to interleukin-9 is not a single linear pathway but a network of transcriptional, secretory and metabolic changes that vary by cell type and context. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanism, key genes, disease links and experimental models used to interrogate GO:0071104.
response to interleukin-9 At A Glance
| GO ID | GO:0071104 |
|---|---|
| GO term | response to interleukin-9 |
| Ontology | biological_process |
| Synonym | response to IL-9 |
| Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus. |
| Major function | Mediates cellular and organismal responses to the cytokine interleukin-9, including immune activation, antibody production and tissue repair. |
| Primary ligand | Interleukin-9 (IL-9), produced by CD4+ T helper cells such as Th9 and T follicular helper cells. |
| Key target cells | B cells, T cells, mast cells, epithelial cells, macrophages and hepatocytes. |
| Related disease areas | Allergy, asthma, fibrosis, cancer, alcoholic liver injury and spondyloarthritis. |
What Is GO:0071104?
In our own words, GO:0071104 (response to interleukin-9) refers to the collection of cellular and organismal processes that are initiated or altered when a cell senses interleukin-9. These changes can include movement, secretion, enzyme production and gene expression, and they are triggered specifically by an IL-9 stimulus rather than by other cytokines. The term is a biological process annotation and is synonymous with response to IL-9.
Why Is response to interleukin-9 Important in Cell Biology?
GO:0071104 is important because interleukin-9 sits at the intersection of type 2 immunity, humoral immunity and tissue remodeling, and its dysregulation is implicated in diseases ranging from asthma and fibrosis to cancer and liver injury. Understanding the response to interleukin-9 at the molecular level provides mechanistic entry points for therapeutic modulation and for interpreting genetic associations with cytokine polymorphisms.
• IL-9 responses promote T follicular helper cell activation and antibody production, directly linking GO:0071104 to vaccine and humoral immunity research.
• An IL-9-ZBTB18 axis drives germinal center development of memory B cells, making this term relevant to B cell memory and autoimmune disease.
• Type 2 immunity, in which IL-9 is a key cytokine, controls tissue repair and fibrosis, so this term is central to wound healing and fibrotic disease research.
• IL-9 attenuates inflammatory responses and hepatocyte apoptosis in alcoholic liver injury, highlighting protective roles of this response.
• Single-cell studies of allergen-specific T cells in allergy and asthma reveal IL-9-associated transcriptional programs, supporting its clinical relevance.
• IL-9 has context-dependent roles in cancer, with evidence for both pro-tumor and anti-tumor effects depending on the tumor microenvironment.
• Polymorphisms in IL-9 and IL-5 affect the response to anti-TNF treatment in ankylosing spondylitis, linking this GO term to pharmacogenomics.
• The response to interleukin-9 is a tractable model for studying cytokine-driven gene expression and secretion in diverse cell types.
• CRISPR-based models enable causal testing of genes acting within this response, accelerating target validation.
What Happens During response to interleukin-9?
IL-9 production and availability
In simple terms: First, immune cells make and release interleukin-9 so it can reach target cells.
The response to interleukin-9 begins with the production of IL-9, primarily by CD4+ T helper cells including Th9 cells and T follicular helper cells. IL-9 availability is influenced by the differentiation state of these T cells and by the local cytokine milieu, and single-cell transcriptomic studies of allergen-specific T cells have identified IL-9-expressing populations in allergic and asthmatic contexts. The amount and timing of IL-9 production therefore set the threshold for downstream signaling events annotated under GO:0071104.
Receptor engagement and signal transduction
In simple terms: IL-9 binds to its receptor on target cells, switching on internal signaling that changes gene expression.
Once released, IL-9 engages the IL-9 receptor complex on target cells, initiating intracellular signaling that alters gene expression, enzyme production and secretion. This receptor engagement is the defining trigger for GO:0071104, and the downstream transcriptional changes can reprogram target cells toward activation, survival or effector functions depending on context. The signaling cascade is modulated by the cell type and by co-stimulatory signals present in the microenvironment.
Activation of T follicular helper cells and B cell help
In simple terms: IL-9 helps specialized T cells activate B cells, boosting antibody responses.
A major functional output of the response to interleukin-9 is the activation of T follicular helper cells, which promote antibody responses. IL-9 mediates this activation and thereby supports the germinal center reaction, a specialized structure where B cells undergo affinity maturation. This step links GO:0071104 directly to humoral immunity and to the quality of antibody responses after infection or vaccination.
Germinal center development and memory B cell formation
In simple terms: IL-9 signaling helps B cells mature into memory cells inside germinal centers.
An IL-9-ZBTB18 axis promotes germinal center development of memory B cells, identifying ZBTB18 as a downstream mediator of the response to interleukin-9 in B cells. This axis supports the formation of memory B cells, which are essential for long-lived protective immunity. The finding that IL-9 signaling intersects with a transcriptional repressor such as ZBTB18 illustrates how GO:0071104 encompasses gene expression changes that shape cell fate.
Tissue repair, fibrosis and inflammatory modulation
In simple terms: IL-9 responses can either help repair tissue or drive fibrosis, depending on the situation.
Type 2 immunity, in which IL-9 is a key cytokine, regulates tissue repair and fibrosis, so the response to interleukin-9 can promote restorative processes or pathological scarring depending on context. In alcoholic liver injury, IL-9 attenuates inflammatory responses and hepatocyte apoptosis, demonstrating a protective role for this response in the liver. These divergent outcomes highlight the importance of cell type and tissue microenvironment in determining the functional consequences of GO:0071104.
Context-dependent roles in cancer
In simple terms: In cancer, IL-9 responses can either fight tumors or help them grow, depending on the tumor.
The role of interleukin-9 in cancer is context-dependent, with evidence supporting both anti-tumor and pro-tumor effects. This duality means that the response to interleukin-9 annotated by GO:0071104 must be interpreted within the specific tumor microenvironment and immune cell composition. Understanding these context-dependent mechanisms is essential for evaluating IL-9 pathway components as therapeutic targets.
Key Genes Involved in GO:0071104 response to interleukin-9
The following genes and proteins are central to the response to interleukin-9 (GO:0071104), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL9 | Encodes interleukin-9, the cytokine ligand that triggers GO:0071104 | Target for knockout and overexpression studies of cytokine production |
| IL9R | Encodes the interleukin-9 receptor that mediates signal transduction | Essential for receptor engagement and downstream signaling assays |
| ZBTB18 | Transcriptional repressor acting in the IL-9-ZBTB18 axis | Mediates germinal center development of memory B cells |
| BCL6 | Master transcription factor of germinal center B cells and T follicular helper cells | Contextual marker of IL-9-driven germinal center responses |
| CD4 | Marker of T helper cells that produce IL-9 | Used to identify Th9 and T follicular helper cells in IL-9 studies |
| IL4 | Cytokine that cooperates with IL-9 in type 2 immunity | Context for Th9 differentiation and type 2 responses |
| IL5 | Type 2 cytokine with polymorphisms linked to anti-TNF response | Studied alongside IL-9 in spondyloarthritis pharmacogenomics |
| TNF | Pro-inflammatory cytokine whose blockade is affected by IL-9/IL-5 polymorphisms | Relevant to anti-TNF treatment response studies |
| STAT6 | Canonical transcription factor in type 2 cytokine signaling | Downstream mediator in type 2 immunity contexts |
| GATA3 | Transcription factor driving Th2 and Th9 programs | Regulates IL-9 expression in T helper cells |
| IRF4 | Transcription factor supporting Th9 and T follicular helper differentiation | Contributes to IL-9 production and response context |
| BATF | Transcription factor involved in Th9 and effector T cell programs | Modulates IL-9-associated transcriptional networks |
| PU.1 | Transcription factor implicated in Th9 differentiation | Context-dependent regulator of IL-9 expression |
| FOXP3 | Regulatory T cell transcription factor that can influence IL-9 responses | Relevant to immune tolerance and IL-9 crosstalk |
| MHC class II | Antigen presentation machinery in B cells and APCs | Linked to T follicular helper and germinal center responses |
| CD40 | Co-stimulatory receptor on B cells | Supports germinal center and memory B cell formation with IL-9 |
| IL2 | Cytokine supporting T cell activation and Th9 differentiation | Context for IL-9 production in T cells |
| PRDM1 | Transcriptional regulator of plasma cell and B cell differentiation | Downstream context of IL-9-driven B cell responses |
How Is response to interleukin-9 Regulated?
The response to interleukin-9 is regulated at multiple levels, including the differentiation state of IL-9-producing T cells, the availability of the IL-9 receptor on target cells, and downstream transcriptional networks. Cytokine milieu and co-stimulatory signals shape whether IL-9 drives antibody responses, tissue repair or inflammation. In B cells, the IL-9-ZBTB18 axis provides a transcriptional checkpoint for germinal center development, illustrating how downstream regulators can modulate the response. Polymorphisms in IL-9 and related type 2 cytokine genes can also influence treatment responses, indicating genetic regulation of this pathway.
response to interleukin-9 and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL9 | Allergy and asthma | Knockout and overexpression in T cell lines and primary T cells |
| ZBTB18 | Germinal center and memory B cell biology | Knockout and point-mutation models in B cell lines |
| IL9R | Inflammatory and fibrotic disease | Knockout in epithelial and immune cell lines |
| IL9 / IL5 | Ankylosing spondylitis anti-TNF response | Genotyping and knock-in of polymorphism variants |
| IL9 | Alcoholic liver injury | Hepatocyte knockout and overexpression models |
Allergy and asthma
Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma has identified IL-9-associated transcriptional programs, supporting a role for the response to interleukin-9 in allergic inflammation and airway disease. Type 2 immunity, in which IL-9 participates, is a central driver of allergic pathology and tissue remodeling. These findings position GO:0071104 as a relevant process for studying asthma mechanisms and therapeutic targets.
Fibrosis and tissue repair
Type 2 immunity regulates tissue repair and fibrosis, and IL-9 is a key cytokine within this network. Depending on context, the response to interleukin-9 can promote restorative tissue remodeling or contribute to pathological fibrosis. This dual role makes GO:0071104 important for understanding fibrotic diseases and for designing interventions that preserve repair while limiting scarring.
Cancer
The role of interleukin-9 in cancer is context-dependent, with evidence for both anti-tumor and pro-tumor effects. Because the response to interleukin-9 can shape immune cell activation and the tumor microenvironment, its contribution varies by tumor type and stage. Researchers studying GO:0071104 in oncology must therefore account for this duality when interpreting experimental results.
Liver injury and spondyloarthritis
IL-9 attenuates inflammatory responses and hepatocyte apoptosis in alcoholic liver injury, indicating a protective role for the response to interleukin-9 in the liver. In ankylosing spondylitis, polymorphisms in Th2 cytokines including IL-9 and IL-5 affect the response to anti-TNF treatment, linking this GO term to pharmacogenomic variability. Together, these findings show that GO:0071104 is relevant to both tissue-specific injury and treatment response.
From response to interleukin-9-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IL-9 drive T follicular helper activation? | IL9 knockout and overexpression in T cell lines and primary T cells |
| How does ZBTB18 mediate IL-9-driven memory B cell formation? | ZBTB18 knockout and point-mutation in B cell lines |
| Does IL-9 protect hepatocytes from apoptosis? | IL9 overexpression and knockout in hepatocyte models |
| Which receptor domains are required for IL-9 signaling? | IL9R point-mutation and knock-in models |
| What transcriptional programs does IL-9 induce in allergic T cells? | Tagged knock-in reporters and RNA-seq in primary T cells |
| Can IL-9 pathway genes be targeted in cancer models? | Knockout and overexpression in tumor and immune cell lines |
How to Study the response to interleukin-9 Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Profiling response to IL-9 in target cells |
| Single-cell RNA-seq | Cell-type-specific transcriptional programs | Allergen-specific T cells in asthma and allergy |
| Antibody production assays | Humoral immune output | T follicular helper and B cell activation |
| Germinal center assays | Memory B cell formation | IL-9-ZBTB18 axis studies |
| Hepatocyte apoptosis assays | Cell death and inflammation | Alcoholic liver injury models |
| Tumor models | Tumor growth and immune infiltration | Context-dependent IL-9 roles in cancer |
| Genotyping | Cytokine polymorphism status | Anti-TNF response in spondyloarthritis |
Transcriptomic profiling
RNA-seq and single-cell RNA-seq are used to capture the gene expression changes that define the response to interleukin-9 in target cells. Single-cell transcriptomic analysis of allergen-specific T cells has revealed IL-9-associated programs in allergy and asthma, demonstrating the power of this approach for GO:0071104 research. These methods help identify downstream effectors and cell-type-specific responses.
Functional immune assays
Antibody production assays, germinal center models and T follicular helper activation assays are used to measure functional outputs of the response to interleukin-9. These assays connect molecular changes to immune outcomes such as memory B cell formation and antibody responses. They are essential for validating causal roles of genes within GO:0071104.
Disease-relevant models
Alcoholic liver injury models and cancer models are used to study the context-dependent roles of the response to interleukin-9. Hepatocyte apoptosis and inflammatory readouts in liver injury models have shown protective effects of IL-9. Tumor models help dissect the dual roles of IL-9 in cancer.
Genetic and pharmacogenomic approaches
Genotyping of cytokine polymorphisms and correlation with treatment response is used to link the response to interleukin-9 to clinical outcomes. Studies in ankylosing spondylitis have shown that IL-9 and IL-5 polymorphisms affect anti-TNF treatment response. These approaches complement mechanistic studies of GO:0071104.
How CRISPR Can Be Used to Study GO:0071104 response to interleukin-9
Knockout
CRISPR knockout of IL9, IL9R or downstream genes such as ZBTB18 allows researchers to test whether these genes are required for the response to interleukin-9. Knockout models can reveal loss-of-function phenotypes in antibody production, germinal center formation or hepatocyte survival. These experiments provide causal evidence linking specific genes to GO:0071104.
Point Mutation
Point-mutation models can be used to dissect specific residues or regulatory elements within genes acting in the response to interleukin-9. For example, targeted mutations in ZBTB18 or IL9R can test the importance of individual domains for downstream signaling. Such models refine the mechanistic understanding of GO:0071104 beyond simple loss-of-function.
Knock-in
Knock-in of tagged or reporter alleles enables tracking of IL-9 pathway components in live cells and tissues. Tagged knock-in models can be used to monitor expression of IL9 or downstream effectors during immune responses. These tools support precise mapping of when and where the response to interleukin-9 occurs.
Overexpression
Overexpression of IL9 or downstream mediators can test sufficiency for driving the response to interleukin-9 in target cells. Overexpression models are useful for studying gain-of-function effects in hepatocytes, T cells and B cells. They complement knockout approaches to establish bidirectional causality within GO:0071104.
How EDITGENE Supports response to interleukin-9 Research
Researchers studying response to interleukin-9-related genes often need to determine whether a candidate gene is causally involved in IL-9-driven phenotypes such as T follicular helper activation, memory B cell formation, hepatocyte protection or tumor modulation. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of these hypotheses across immune, epithelial and hepatic cell types.
Contact EDITGENE today to design your custom CRISPR model for response to interleukin-9 research.
Frequently Asked Questions About response to interleukin-9
What is GO:0071104?
GO:0071104 is the Gene Ontology biological process term response to interleukin-9, defined as any process that results in a change in state or activity of a cell or an organism as a result of an interleukin-9 stimulus.
What is response to interleukin-9?
It is the collection of cellular and organismal changes triggered by interleukin-9, including movement, secretion, enzyme production and gene expression.
What genes are involved in response to interleukin-9?
Key genes include IL9, IL9R, ZBTB18, BCL6, CD4, GATA3, IRF4 and other type 2 immunity regulators.
How does IL-9 signal in immune cells?
IL-9 binds its receptor on target cells and initiates signaling that alters gene expression and effector functions, including T follicular helper activation and memory B cell formation.
What diseases are linked to response to interleukin-9?
Allergy, asthma, fibrosis, cancer, alcoholic liver injury and ankylosing spondylitis anti-TNF response have been linked to IL-9 biology.
What is the role of IL-9 in cancer?
IL-9 has context-dependent roles in cancer, with evidence for both anti-tumor and pro-tumor effects depending on the tumor microenvironment.
How is IL-9 involved in antibody responses?
IL-9 mediates T follicular helper cell activation to promote antibody responses and supports germinal center development of memory B cells via a ZBTB18 axis.
Can CRISPR be used to study response to interleukin-9?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are used to test causal roles of genes in IL-9-driven phenotypes.
What methods are used to study GO:0071104?
RNA-seq, single-cell RNA-seq, antibody production assays, germinal center assays, hepatocyte apoptosis assays, tumor models and genotyping are commonly used.
Why is response to interleukin-9 important for drug development?
Because IL-9 pathway polymorphisms affect anti-TNF treatment response and IL-9 has context-dependent roles in cancer and fibrosis, the pathway is a candidate for therapeutic modulation.
Conclusion
GO:0071104 (response to interleukin-9) captures the diverse cellular and organismal changes triggered by IL-9, from T follicular helper activation and memory B cell formation to tissue repair, fibrosis and context-dependent cancer outcomes. The term is supported by a growing body of literature linking IL-9 biology to allergy, asthma, liver injury and pharmacogenomic variability in anti-TNF response. For researchers, the response to interleukin-9 offers a tractable system for dissecting cytokine-driven gene expression and immune cell crosstalk using CRISPR-based models and transcriptomic profiling. EDITGENE provides the knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services needed to interrogate this pathway with rigor and reproducibility.
References
- 1. Sato T et al.. 2024. Interleukin 9 mediates T follicular helper cell activation to promote antibody responses.. Front Immunol 15:1441407 PMID: 39403384
- 2. Luo X et al.. 2025. An interleukin-9-ZBTB18 axis promotes germinal center development of memory B cells.. Immunity 58(4):861-874.e6 PMID: 40107273
- 3. Gieseck RL 3rd et al.. 2018. Type 2 immunity in tissue repair and fibrosis.. Nat Rev Immunol 18(1):62-76 PMID: 28853443
- 4. Meng H et al.. 2022. Interleukin-9 attenuates inflammatory response and hepatocyte apoptosis in alcoholic liver injury.. Life Sci 288:120180 PMID: 34843736
- 5. Seumois G et al.. 2020. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma.. Sci Immunol 5(48) PMID: 32532832
- 6. Pajulas A et al.. 2023. The World according to IL-9.. J Immunol 211(1):7-14 PMID: 37339404
- 7. Lee JE et al.. 2020. The Role of Interleukin-9 in Cancer.. Pathol Oncol Res 26(4):2017-2022 PMID: 31016637
- 8. Biały S et al.. 2022. Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis.. Int J Mol Sci 23(21) PMID: 36361964
